• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human AMY-1-associating protein expressed in testis 1 (AAT1)

ACP15596

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP15596 Target NameMAATS1
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range1-603Protein LengthFull length protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ7Z4T9
Background Information
  • Uniprot Id

    Q7Z4T9

  • Target Species

    Human

  • Target Name

    CFAP91

  • Target Full Name

    Cilia- and flagella-associated protein 91

  • Target Function

    May play a role in spermatogenesis. May regulate cilium motility through its role in the assembly of the axonemal radial spokes.

  • Target Subcellular Location

    Mitochondrion. Cytoplasm. Cytoplasm, cytoskeleton, cilium axoneme.

  • Target Tissue Specificity

    [Isoform 1]: Strongly expressed in the liver.; [Isoform 3]: Expressed in the testis.; [Isoform 7]: Widely expressed, but strongly expressed in all spermatogenesis-related tissues, including the testis, the epithelium of cauda and the corpus epididymis, as

  • Target Synonyms

    MAATS1; AAT1; C3orf15; CFAP91; Cilia- and flagella-associated protein 91; CFAP91; AMY-1-associating protein expressed in testis 1; AAT-1; MYCBP/AMY-1-associated testis-expressed protein 1; Protein MAATS1

Inquire Recombinant Human AMY-1-associating protein expressed in testis 1 (AAT1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification